Maj has a quick discussion with Cryo-cell International, Inc. (NASDAQ:CCEL) CEO David Portnoy about current events going on at the company. CCEL provides private and public cord blood banking solutions for stem cell treatments.
Specifically, David addressed questions on:
- Revenue trends
- Birth rate cause & effect on CCEL
- Pricing environment
- The company’s stem cell clinic expansion plans
- FDA approval goals
- Therapy pipeline
Enjoy these clips before watching the full video.
David Portnoy on Neurological Indications in Focus
David Portnoy on Planned Clinic Opening
With a Subscription, you will also receive full access to our entire research service platform which includes, but is not limited to….
- Access to our entire catalog of microcap stock coverage, spanning 14 years.
- Timely alerts on new Bullish Stock Ideas and Related Updates on our entire Tier One Quality Microcap coverage universe.
- Clear opinions on our convictions, valuations and changes in our conviction.
- All ideas supported by Research Reports and in-depth Due Diligence.
- Access to our Model Portfolio of high conviction ideas.
- Portfolio Protection Research and related Red Flag Alerts.
- Participation in all Live Interviews, Fireside Chats and Q&As with microcap company executives.
- Participation in our Monthly Open Forums to discuss Geo’s microcap coverage. Hosted by Co-Founder Maj Soueidan.
- “GeoWire” monthly and weekly newsletter which includes our Weekly Wrap-Up, curated for our Premium Subscribers, highlighting our research coverage and stock idea generation that took place during the week.
- Access to all premium audio and video podcasts featuring our stock pitches and educational content.
- Stock ideas from handpicked Research Contributors who have proven to beat the market.